JPWO2021011689A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021011689A5 JPWO2021011689A5 JP2022502302A JP2022502302A JPWO2021011689A5 JP WO2021011689 A5 JPWO2021011689 A5 JP WO2021011689A5 JP 2022502302 A JP2022502302 A JP 2022502302A JP 2022502302 A JP2022502302 A JP 2022502302A JP WO2021011689 A5 JPWO2021011689 A5 JP WO2021011689A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- pharmaceutically acceptable
- optionally substituted
- acceptable salt
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962874533P | 2019-07-16 | 2019-07-16 | |
| US62/874,533 | 2019-07-16 | ||
| US201962927974P | 2019-10-30 | 2019-10-30 | |
| US62/927,974 | 2019-10-30 | ||
| US202062987653P | 2020-03-10 | 2020-03-10 | |
| US62/987,653 | 2020-03-10 | ||
| US202063049927P | 2020-07-09 | 2020-07-09 | |
| US63/049,927 | 2020-07-09 | ||
| PCT/US2020/042183 WO2021011689A1 (en) | 2019-07-16 | 2020-07-15 | Cd73 inhibitors |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022540890A JP2022540890A (ja) | 2022-09-20 |
| JPWO2021011689A5 true JPWO2021011689A5 (https=) | 2023-05-12 |
| JP2022540890A5 JP2022540890A5 (https=) | 2023-05-12 |
| JP7557522B2 JP7557522B2 (ja) | 2024-09-27 |
Family
ID=74209960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022502302A Active JP7557522B2 (ja) | 2019-07-16 | 2020-07-15 | Ｃｄ７３阻害剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12544391B2 (https=) |
| EP (1) | EP3999517A4 (https=) |
| JP (1) | JP7557522B2 (https=) |
| WO (1) | WO2021011689A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018208980A1 (en) | 2017-05-10 | 2018-11-15 | Oric Pharmaceuticals, Inc. | Cd73 inhibitors |
| US11377469B2 (en) | 2017-11-03 | 2022-07-05 | Oric Pharmaceuticals, Inc. | CD73 inhibitors |
| CN112423764A (zh) | 2018-04-30 | 2021-02-26 | 欧瑞克制药公司 | Cd73抑制剂 |
| US12544391B2 (en) | 2019-07-16 | 2026-02-10 | Oric Pharmaceuticals, Inc. | CD73 inhibitors |
| HUE072504T2 (hu) | 2019-10-30 | 2025-11-28 | Oric Pharmaceuticals Inc | CD73-inhibitorok |
| AU2023249795A1 (en) | 2022-04-08 | 2024-10-17 | Shy Therapeutics, Llc | Compounds that interact with ras superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
| CN119173276A (zh) | 2022-04-13 | 2024-12-20 | 吉利德科学公司 | 用于治疗表达Trop-2的癌症的组合疗法 |
| WO2025096605A1 (en) * | 2023-10-31 | 2025-05-08 | Oric Pharmaceuticals, Inc. | Cd73 inhibitor and anti-cd38 agent combination therapy |
| WO2025137640A1 (en) | 2023-12-22 | 2025-06-26 | Gilead Sciences, Inc. | Azaspiro wrn inhibitors |
| CN118359622B (zh) * | 2024-04-16 | 2025-08-26 | 上海陶术生物科技股份有限公司 | 加利司伟中间体的制备方法 |
| WO2025233264A1 (en) | 2024-05-07 | 2025-11-13 | Innate Pharma | Use of cd73 blocking agents in combination with anti-cd20 x cd3 t cell engagers |
| CN119552122B (zh) * | 2025-01-27 | 2025-05-09 | 北京悦康科创医药科技股份有限公司 | 5'-磷酸酯修饰核苷及其制备方法与应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0477454A1 (en) | 1990-09-28 | 1992-04-01 | Merrell Dow Pharmaceuticals Inc. | Novel phosphonate derivatives of certain nucleosides |
| WO2002048165A2 (en) | 2000-12-15 | 2002-06-20 | Pharmasset Ltd. | Antiviral agents for treatment of flaviviridae infections |
| US20040229839A1 (en) | 2003-05-14 | 2004-11-18 | Biocryst Pharmaceuticals, Inc. | Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
| WO2005020885A2 (en) | 2003-05-21 | 2005-03-10 | Isis Pharmaceuticals, Inc. | Compositions and methods for the treatment of severe acute respiratory syndrome (sars) |
| WO2007139946A2 (en) | 2006-05-25 | 2007-12-06 | University Of Tennessee Research Foundation | Gpcr ligands identified by computational modeling |
| DE102007001370A1 (de) | 2007-01-09 | 2008-07-10 | Curevac Gmbh | RNA-kodierte Antikörper |
| WO2009127230A1 (en) | 2008-04-16 | 2009-10-22 | Curevac Gmbh | MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION |
| US20090274686A1 (en) | 2008-05-02 | 2009-11-05 | Yat Sun Or | Nucleoside phosphonate derivatives |
| WO2015164573A1 (en) * | 2014-04-25 | 2015-10-29 | Vitae Pharmaceuticals, Inc. | Purine derivatives as cd73 inhibitors for the treatment of cancer |
| CN104530166B (zh) | 2014-12-04 | 2016-08-24 | 陕西汉江药业集团股份有限公司 | 选择性还原4,6-共轭双烯-3-酮甾体化合物的方法 |
| EA036379B1 (ru) | 2014-12-12 | 2020-11-02 | Блубёрд Био, Инк. | Химерные антигенные рецепторы к bcma |
| WO2017098421A1 (en) | 2015-12-08 | 2017-06-15 | Glaxosmithkline Intellectual Property Development Limited | Benzothiadiazine compounds |
| HUE063388T2 (hu) | 2016-01-08 | 2024-01-28 | Arcus Biosciences Inc | Ekto-5'-nukleotidáz modulátorok és ezek alkalmazása |
| TWI767937B (zh) | 2016-09-09 | 2022-06-21 | 美商卡利泰拉生物科技公司 | 外核苷酸酶抑制劑及其使用方法 |
| CN110049767B (zh) * | 2016-10-03 | 2023-04-04 | 艾库斯生物科学有限公司 | 腺苷5′-核苷酸酶的抑制剂 |
| EP3541396A4 (en) | 2016-11-18 | 2020-07-22 | Arcus Biosciences, Inc. | CD73-MEDIATED IMMUNOSUPPRESSION INHIBITORS |
| JP7138351B2 (ja) | 2016-12-22 | 2022-09-16 | キャリセラ バイオサイエンシーズ， インコーポレイテッド | エクトヌクレオチダーゼ阻害剤およびその使用方法 |
| US20200115404A1 (en) * | 2017-03-31 | 2020-04-16 | Peloton Therapeutics, Inc. | Cd73 inhibitors and uses thereof |
| WO2018208727A1 (en) | 2017-05-08 | 2018-11-15 | Eternity Bioscience Inc. | Nucleoside and nucleotide analogues as cd73 inhibitors and therapeutic uses thereof |
| WO2018208980A1 (en) | 2017-05-10 | 2018-11-15 | Oric Pharmaceuticals, Inc. | Cd73 inhibitors |
| US11377469B2 (en) | 2017-11-03 | 2022-07-05 | Oric Pharmaceuticals, Inc. | CD73 inhibitors |
| WO2019129059A1 (zh) | 2017-12-29 | 2019-07-04 | 上海和誉生物医药科技有限公司 | 一种具有cd73抑制活性的膦酸衍生物、其制备方法和应用 |
| CN112423764A (zh) | 2018-04-30 | 2021-02-26 | 欧瑞克制药公司 | Cd73抑制剂 |
| EP3810109B1 (en) * | 2018-05-31 | 2024-08-07 | Peloton Therapeutics, Inc. | Compounds and compositions for inhibiting cd73 |
| AU2019288495B2 (en) | 2018-06-21 | 2024-02-08 | Antengene Therapeutics Limited | Ectonucleotidase inhibitors and methods of use thereof |
| EP3843714B1 (en) | 2018-08-27 | 2025-11-12 | Arcus Biosciences, Inc. | Cd73 inhibitors |
| KR20220024629A (ko) | 2019-06-20 | 2022-03-03 | 칼리테라 바이오사이언시즈, 인코포레이티드 | 엑토뉴클레오티다제 억제제 및 이의 사용 방법 |
| US12544391B2 (en) | 2019-07-16 | 2026-02-10 | Oric Pharmaceuticals, Inc. | CD73 inhibitors |
| HUE072504T2 (hu) | 2019-10-30 | 2025-11-28 | Oric Pharmaceuticals Inc | CD73-inhibitorok |
-
2020
- 2020-07-15 US US17/626,731 patent/US12544391B2/en active Active
- 2020-07-15 WO PCT/US2020/042183 patent/WO2021011689A1/en not_active Ceased
- 2020-07-15 JP JP2022502302A patent/JP7557522B2/ja active Active
- 2020-07-15 EP EP20841341.9A patent/EP3999517A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021011689A5 (https=) | ||
| JP2020506178A5 (https=) | ||
| JP2020536881A5 (https=) | ||
| JP2020506951A5 (https=) | ||
| JPWO2020243415A5 (https=) | ||
| IL283592B2 (en) | Inhibitors of apol1 and methods of using same | |
| RU92004336A (ru) | Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты | |
| RU2010106878A (ru) | Комбинация антимитотического агента и ингибитора аврора киназы как средство для лечения рака | |
| RU2017136715A (ru) | Производное имидазоизоиндола, способ его получения и медицинское применение | |
| Metwally et al. | Synthesis and anticancer activity of some new thiopyrano [2, 3-d] thiazoles incorporating pyrazole moiety | |
| JP2015501292A5 (https=) | ||
| JP2021534108A5 (https=) | ||
| JP2017519754A5 (https=) | ||
| Wong et al. | A new synthesis of. beta.-lactams | |
| CN111601797A (zh) | 苯并哌啶或杂芳基并哌啶类衍生物、其制备方法及其在医药上的应用 | |
| JP2006509842A5 (https=) | ||
| JPWO2019149164A5 (https=) | ||
| HUP0103937A2 (hu) | Izoszorbid-mononitrát-származékok és alkalmazásuk csökkentett toleranciával járó értágítószerekként | |
| JPWO2019213445A5 (https=) | ||
| JPWO2020033490A5 (https=) | ||
| JPWO2021133896A5 (https=) | ||
| JPWO2020033520A5 (https=) | ||
| JPWO2019209757A5 (https=) | ||
| JP2005531563A5 (https=) | ||
| JP2022549030A (ja) | 複素環アミド化合物、その薬学的に許容される塩およびその調製方法と使用 |